QL-IX-55 是一种选择性的 ATP 竞争性 mTORC1/2 抑制剂，对人 mTORC1/酵母 mTORC1/酵母 mTORC2 的 IC50 分别为 50/50/10-50 nM。
| Cas No. | 1223002-54-7 |
| 别名 | 9-(6-氨基-3-吡啶基)-1-[4-氟-3-(三氟甲基)苯基]苯并[H]-1,6-萘啶-2(1H)-酮 |
| 化学名 | 9-(6-aminopyridin-3-yl)-1-(4-fluoro-3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one |
| Canonical SMILES | O=C1C=CC2=CN=C3C=CC(C4=CN=C(N)C=C4)=CC3=C2N1C5=CC(C(F)(F)F)=C(F)C=C5 |
| 分子式 | C24H14F4N4O |
| 分子量 | 450.39 |
| 溶解度 | Soluble in DMSO |
| 储存条件 | Store at -20℃ |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | The functional target of QL-IX-55 is the ATP-binding site of TOR2 as evidenced by the discovery of resistant alleles of TOR2 through rational design and unbiased selection strategies. QL-IX-55 is capable of potently inhibiting both TOR complex 1 and 2 (TORC1 and TORC2) as demonstrated by biochem. IP kinase assays (IC50 <50 nM) and cellular assays for inhibition of substrate YPK1 phosphorylation. In contrast to rapamycin, QL-IX-55 is capable of inhibiting TORC2-dependent transcription, which suggests that this compd. will be a powerful probe to dissect the Tor2/TORC2-related signaling pathway in yeast. |
m.cnreagent.com